Diagnostic chain operator Thyrocare Technologies (NSE:THYROCARE, BOM:539871) has agreed to invest an additional $25,000 in its joint venture company Thyrocare Laboratories (Tanzania), according to a Monday filing to the Indian stock exchanges,
Following the investment and on the allotment of shares by the JV company, Thyrocare Laboratories (Tanzania) will become a subsidiary of the company.
The joint venture company provides diagnostic and healthcare services directly to customers in Tanzania.
Price (INR): ₹659.50, Change: ₹-3.6, Percent Change: -0.54%
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。